FI900536A0 - Anti-inflammatoriska arylkompositioner. - Google Patents
Anti-inflammatoriska arylkompositioner.Info
- Publication number
- FI900536A0 FI900536A0 FI900536A FI900536A FI900536A0 FI 900536 A0 FI900536 A0 FI 900536A0 FI 900536 A FI900536 A FI 900536A FI 900536 A FI900536 A FI 900536A FI 900536 A0 FI900536 A0 FI 900536A0
- Authority
- FI
- Finland
- Prior art keywords
- arylkompositioner
- inflammatory
- compounds
- halophenyl
- phenylene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C233/05—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898902472A GB8902472D0 (en) | 1989-02-03 | 1989-02-03 | Anti-inflammatory aryl derivatives |
GB898919314A GB8919314D0 (en) | 1989-08-25 | 1989-08-25 | Anti-inflammatory aryl derivatives |
GB898924867A GB8924867D0 (en) | 1989-11-03 | 1989-11-03 | Anti-inflammatory aryl derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
FI900536A0 true FI900536A0 (fi) | 1990-02-02 |
Family
ID=27264299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI900536A FI900536A0 (fi) | 1989-02-03 | 1990-02-02 | Anti-inflammatoriska arylkompositioner. |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0384594B1 (fi) |
JP (1) | JPH02270855A (fi) |
KR (1) | KR900012892A (fi) |
AT (1) | ATE96427T1 (fi) |
AU (1) | AU624896B2 (fi) |
CA (1) | CA2009201A1 (fi) |
DE (1) | DE69004119T2 (fi) |
DK (1) | DK0384594T3 (fi) |
ES (1) | ES2060015T3 (fi) |
FI (1) | FI900536A0 (fi) |
HU (1) | HU208523B (fi) |
IL (1) | IL93259A0 (fi) |
MC (1) | MC2091A1 (fi) |
NO (1) | NO171906C (fi) |
NZ (1) | NZ232350A (fi) |
PT (1) | PT93049A (fi) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5120752A (en) * | 1989-12-28 | 1992-06-09 | Abbott Laboratories | Cyclopropyl derivative lipoxygenase inhibitors |
US5476873A (en) * | 1990-07-25 | 1995-12-19 | Abbott Laboratories | Acetylene derivatives having lipoxygenase inhibitory activity |
JPH06256285A (ja) * | 1990-12-11 | 1994-09-13 | Pfizer Pharmaceut Co Ltd | ヒドロキサム酸誘導体およびその用途 |
US5130485A (en) * | 1991-04-23 | 1992-07-14 | Eli Lilly And Company | N-hydroxy-N-(3-(2-substituted phenyl)prop-2-enyl)ureas and thioureas useful as 5-lipoxygenase inhibiting agents |
US5283361A (en) * | 1991-04-23 | 1994-02-01 | Eli Lilly And Company | N-hydroxy-N-[3-[2-(halophenylthio)phenyl]prop-2-enyl]ureas as lipoxygenase inhibitors |
US5140047A (en) * | 1991-05-03 | 1992-08-18 | Smithkline Beecham Corporation | Lipoxygenase inhibitors |
DE4204686A1 (de) * | 1992-02-17 | 1993-08-19 | Gruenenthal Gmbh | Imidazolylphenolderivate, diese enthaltende arzneimittel sowie ein verfahren zur herstellung dieser verbindungen und arzneimitteln |
US5326787A (en) * | 1992-05-12 | 1994-07-05 | Abbott Laboratories | Cycloalkyl N-hydroxy derivatives having lipoxygenase inhibitory activity |
GB9308652D0 (en) * | 1993-04-27 | 1993-06-09 | Wellcome Found | Anti-inflammatory compounds |
TW448144B (en) * | 1993-08-19 | 2001-08-01 | Pfizer | Phenoxyphenyl cyclopentenyl hydroxyureas |
US5459154A (en) * | 1993-11-08 | 1995-10-17 | American Home Products Corporation | N-hydroxyureas as 5-lipoxygenase inhibitors and inhibitors of oxidative modification of low density lipoprotein |
US5428048A (en) * | 1993-11-08 | 1995-06-27 | American Home Products Corporation | Aryl-N-hydroxyureas as inhibitors of 5-lipoxygenase and anto-arteriosclerotic agents |
US5468760A (en) * | 1993-11-08 | 1995-11-21 | American Home Products Corporation | Aralkyl-N-hydroxyureas as inhibitors of 5-lipoxygenase and oxidation of low density lipoprotein |
EP0891772A3 (en) * | 1997-06-18 | 1999-05-19 | Santen Pharmaceutical Co., Ltd. | Therapeutic agent for rheumatic disease comprising nonsteroidal anti-inflamatory drug and phenylpropionic acid derivative |
CA2465261A1 (en) * | 2001-10-24 | 2003-05-01 | The Regents Of The University Of California | Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis |
WO2013007371A2 (en) * | 2011-07-13 | 2013-01-17 | Eth Zurich | Kinetic resolution of chiral amines |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU201300B (en) * | 1985-03-16 | 1990-10-28 | Wellcome Found | Process for production of derivatives of aryl and medical compositions containing them as active substance |
US4728670A (en) * | 1986-06-04 | 1988-03-01 | E. R. Squibb & Sons, Inc. | Biphenyl hydroxamic acids |
US4897422A (en) * | 1987-02-10 | 1990-01-30 | Abbott Laboratories | Lipoxygenase inhibiting compounds |
DE3888574T2 (de) * | 1987-04-24 | 1994-06-30 | Abbott Lab | Harnstoff-Derivate mit lipoxygenasehemmender Wirkung. |
PL154186B1 (en) * | 1987-07-15 | 1991-07-31 | Wellcome Found | Method for manufacturing arylic derivatives of the hydroxamic acid |
-
1990
- 1990-02-02 HU HU90656A patent/HU208523B/hu not_active IP Right Cessation
- 1990-02-02 NO NO900504A patent/NO171906C/no unknown
- 1990-02-02 PT PT93049A patent/PT93049A/pt unknown
- 1990-02-02 DE DE90301090T patent/DE69004119T2/de not_active Expired - Fee Related
- 1990-02-02 DK DK90301090.8T patent/DK0384594T3/da active
- 1990-02-02 FI FI900536A patent/FI900536A0/fi not_active IP Right Cessation
- 1990-02-02 ES ES90301090T patent/ES2060015T3/es not_active Expired - Lifetime
- 1990-02-02 MC MC902102A patent/MC2091A1/xx unknown
- 1990-02-02 AT AT90301090T patent/ATE96427T1/de not_active IP Right Cessation
- 1990-02-02 AU AU49088/90A patent/AU624896B2/en not_active Ceased
- 1990-02-02 EP EP90301090A patent/EP0384594B1/en not_active Expired - Lifetime
- 1990-02-02 KR KR1019900001225A patent/KR900012892A/ko not_active Application Discontinuation
- 1990-02-02 CA CA002009201A patent/CA2009201A1/en not_active Abandoned
- 1990-02-02 IL IL93259A patent/IL93259A0/xx unknown
- 1990-02-02 JP JP2024286A patent/JPH02270855A/ja active Pending
- 1990-02-02 NZ NZ232350A patent/NZ232350A/en unknown
Also Published As
Publication number | Publication date |
---|---|
JPH02270855A (ja) | 1990-11-05 |
KR900012892A (ko) | 1990-09-03 |
AU624896B2 (en) | 1992-06-25 |
DE69004119T2 (de) | 1994-03-24 |
HU900656D0 (en) | 1990-04-28 |
PT93049A (pt) | 1990-08-31 |
EP0384594A1 (en) | 1990-08-29 |
ES2060015T3 (es) | 1994-11-16 |
NO171906B (no) | 1993-02-08 |
CA2009201A1 (en) | 1990-08-03 |
DK0384594T3 (da) | 1993-12-06 |
MC2091A1 (fr) | 1991-02-15 |
IL93259A0 (en) | 1990-11-29 |
DE69004119D1 (de) | 1993-12-02 |
NO900504L (no) | 1990-08-06 |
HU208523B (en) | 1993-11-29 |
NO900504D0 (no) | 1990-02-02 |
EP0384594B1 (en) | 1993-10-27 |
NO171906C (no) | 1993-05-19 |
HUT53071A (en) | 1990-09-28 |
ATE96427T1 (de) | 1993-11-15 |
NZ232350A (en) | 1992-04-28 |
AU4908890A (en) | 1990-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI872864A0 (fi) | Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi | |
ES2060015T3 (es) | Derivados arilicos anti-inflamatorios. | |
ZA928170B (en) | Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid | |
IL92730A (en) | 2-aminopyrimidinone derivatives, their preparation and pharmaceutical compositions containing them | |
IT1226727B (it) | Farmaci precursori della dopamina. | |
NO883146D0 (no) | Anti-inflamatorisk aktive arylderivater og fremgangsmaate for deres fremstilling. | |
NO894616L (no) | Fremgangsmaate for fremstilling av anti-aterosklerotisk aktive diarylforbindelser. | |
ATE84035T1 (de) | Antivirale tetrahydroimidazo(1,4)benzodiazepin-2- one. | |
JO1679B1 (en) | A new, therapeutically active compound and method for preparing it | |
TH8696A (th) | สารประกอบแอริลซึ่งต้านการอักเสบ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed | ||
MM | Patent lapsed |
Owner name: THE WELLCOME FOUNDATION LIMITED |